Janssen Inc. v. Teva Canada Ltd. et al., (2015) 475 F.T.R. 238 (FC)
Linked as:
Extract
Janssen Inc. v. Teva Canada Ltd. et al., (2015) 475 F.T.R. 238 (FC)
No longer available (Autolink)
See the full content of this document
This document cites
- Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
- Alcon Canada Inc. et al. v. Apotex Inc. et al., (2012) 433 F.T.R. 1 (FC)
- Apotex Inc. v. Sanofi-Aventis, (2013) 447 N.R. 313 (FCA)
- Shire Biochem Inc. et al. v. Canada (Minister of Health) et al., (2008) 328 F.T.R. 123 (FC)
- Novartis Pharmaceuticals Canada Inc. v. Teva Canada Ltd. et al., (2013) 429 F.T.R. 158 (FC)
